Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Recruiting Observational Study
Lung Adenocarcinoma
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 85
Sex
Any
Study type
Observational
Participants needed
332 (estimated)
Sponsor
Oscar Gerardo Arrieta Rodríguez · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to describe the prevalence of germ line-pathogenic variants in Mexican patients with lung adenocarcinoma. The main questions it aims to answer are: 1. What is the prevalence of pathogenic variants in genes associated with lung adenocarcinoma in Mexican patients younger than fifty? 2. Which clinical-pathological characteristics are associated with germ-line…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Both sexes * ≥ 16 years old, according the institutional protocols for new patients admittances. * histologically confirmed lung adenocarcinoma (LUAD) * Signed written informed consent form * A life expectancy greater than 8 weeks. * Histologically confirmed LUAD and one of th…
Contacts

Oscar G Arrieta Rodriguez, M.D., M.Sc.

5556280400

ogar@unam.mx

CONTACT